Dp-ucMGP drop ≤90% N = 23 | Dp-ucMGP drop >90% N = 27 | P-value | OR (95% CI) | |
---|---|---|---|---|
Age (years), Median (IQR) | 72.0 (55.0; 80.0) | 69.0 (63.0; 79.0) | 0.63 | 1.01 (0.97–1.05) |
Gender, male n (%) | 14 (60) | 16 (59.3) | 1.00 | 1.07 (0.34–3.33) |
Dialysis vintage (months), Median (IQR) | 41.0 (28.0; 112.0) | 48.0 (22.0; 110.0) | 0.68 | 1.02 (0.92–1.14) |
Diabetes, n (%) | 13 (56.5) | 5 (18.5) | 0.01 | 0.17 (0.05–0.62) |
Hypertension, n (%) | 16 (69.6) | 22 (81.5) | 0.32 | 1.92 (0.52–7.18) |
Smoking, n (%) | 3 (13.0) | 5 (18.5) | 0.71 | 1.51 (0.32–7.17) |
Calcification score, Median (IQR) | 3.0 (1.0; 12.0) | 9.0 (4.0; 14.0) | 0.10 | 1.06 (0.97–1.15) |
NCBB, n (%) | 10 (43.5) | 10 (37.0) | 0.64 | 0.76 (0.25–2.38) |
Residual diuresis, n (%) | 3 (13.0) | 3 (11.1) | 1.00 | 0.83 (0.15–4.59) |
Calcium dose, Median (IQR) | 2.0 (1.0; 3.0) | 1.0 (1.0; 2.0) | 0.12 | 0.63 (0.36–1.11) |
Alfacalcidol dose (μg), Median (IQR) | 0.75 (0.00; 1.50) | 0.75 (0.25; 1.50) | 0.20 | 1.17 (0.82–1.69) |
Serum phosphate (mg/dl), Median (IQR) | 3.90 (3.50; 5.00) | 3.90 (3.00; 4.50) | 0.25 | 0.64 (0.39–1.06) |
Serum calcium (mg/dl), Median (IQR) | 9.00 (8.70; 9.30) | 9.20 (8.90; 9.30) | 0.08 | 4.97 (0.82–30.06) |
PTH (pg/ml), Median (IQR) | 153.00 (88.50; 216.00) | 216.0 (144.0; 314.0) | 0.10 | 1.03 (0.98–1.07) |
LDL cholesterol (mg/dl), Median (IQR) | 93.50 (77.75; 114.25) | 92.00 (76.00; 113.25) | 0.61 | 0.99 (0.97–1.02 |
BMI (Kg/m2), Median (IQR) | 26.45 (23.03; 31.39) | 25.26 (22.65; 26.65) | 0.13 | 0.89 (0.78–1.01) |
URR, Median (IQR) | 75.0 (71.0; 79.0) | 74.0 (71.0; 79.0) | 0.70 | 0.98 (0.88–1.10) |
Albumin, Median (IQR) | 37.0 (35.0; 40.0) | 39.0 (37.0; 41.0) | 0.15 | 1.09 (0.94–1.26) |
CAD, n (%) | 7 (30.4) | 7 (25.9) | 0.72 | 0.80 (0.23–2.76) |
Cinacalcet, n (%) | 1 (4.3) | 1 (3.7) | 1.00 | 0.85 (0.05–14.33) |
Previous acenocoumadin, n (%) | 3 (13.0) | 3 (11.1) | 1.00 | 0.83 (0.15–4.59) |
PTHX, n (%) | 0 (0.0) | 2 (7.4) | 0.49 | NA |
Recent fracture, n (%) | 1 (4.3) | 2 (7.4) | 1.00 | 1.76 (0.15–20.76) |